SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads-Reference-Cited by-全球学者库

SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads

Published:2023-11 Issue: Volume:96 Page:129489
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Ghosh Arun K.^ORCID,Shahabi Dana,Imhoff Mackenzie E.C.,Kovela Satish,Sharma Ashish,Hattori Shin-ichiro^ORCID,Higashi-Kuwata Nobuyo,Mitsuya Hiroaki,Mesecar Andrew D.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference50 articles.

1. A novel coronavirus outbreak of global health concern;Wang;Lancet,2020

2. Managing uncertainty in the covid-19 era;Rutter;Br Med J,2020

3. World Health Organization. Coronavirus Disease (COVID-19) Situation Report. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed on).

4. Coronavirus COVID-19 (2019-nCoV). https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6.

5. COVID-19 will continue but the end of the pandemic is near;Murray;Lancet,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor;Pharmaceutics;2024-01-25

2. Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence;Infectious Disease Reports;2023-10-25